6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
31m ago	First Stoping Operations at Perseus Mining's CMA Underground
57m ago	Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
57m ago	Sally Beauty Holdings Announces Conference Call and Webcast to Discuss Second Quarter Financial Results on May 11, 2026
57m ago	CBRE Group, Inc. Announces Pricing of $750 Million Senior Notes due 2036
57m ago	LifeStance Health Group Set to Join S&P SmallCap 600

About

Elanco Animal Health (NYSE:ELAN) — investor relations, events, news, and company updates on 6ix.

Latest News

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Amlan International and Elanco Collaborate on Japanese Educational Seminars Focused on Calf Health

Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

Financials

Revenue

$4.71 B

Market Cap

$11.47 B

EPS

-0.47

Community Chat

Ask AI